Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,874 | 27,215 | 25,091 | 23,918 | 14,763 |
| Receivables | 12,106 | 12,319 | 13,120 | 21,120 | 20,372 |
| Inventories | N/A | N/A | 0 | 2,619 | 2,756 |
| TOTAL | $43,351 | $40,700 | $39,244 | $49,236 | $39,484 |
| Non-Current Assets | |||||
| PPE Net | 6,875 | 8,636 | 10,376 | 12,065 | 12,962 |
| Investments And Advances | 0 | 0 | 59 | 60 | 589 |
| Other Non-Current Assets | 0 | 0 | 0 | 15 | 31 |
| TOTAL | $6,875 | $8,636 | $10,435 | $12,140 | $13,583 |
| Total Assets | $50,226 | $49,336 | $49,679 | $61,377 | $53,067 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 36 | 139 |
| Accounts payable and accrued liabilities | 5,186 | 5,150 | 6,235 | 16,702 | 12,501 |
| TOTAL | $5,358 | $5,764 | $7,463 | $18,010 | $13,451 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,512 | 562 | 569 | 0 | 0 |
| TOTAL | $4,858 | $1,107 | $1,225 | $1,077 | $1,042 |
| Total Liabilities | $10,215 | $6,871 | $8,688 | $19,087 | $14,493 |
| Shareholders' Equity | |||||
| Common Shares | 41,392 | 43,464 | 44,201 | 0 | 0 |
| Retained earnings | -2,031 | -1,671 | -4,148 | -3,378 | -6,246 |
| Other shareholders' equity | -20 | -21 | -21 | -61 | 360 |
| TOTAL | $40,011 | $42,465 | $40,991 | $42,290 | $38,573 |
| Total Liabilities And Equity | $50,226 | $49,336 | $49,679 | $61,377 | $53,067 |